Mark Rubin Selected Research

Mark Rubin Research Topics

Disease

15	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2002
11	Neoplasms (Cancer) 12/2021 - 01/2002
3	Adenocarcinoma 12/2021 - 07/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2014 - 04/2007
3	Disease Progression 02/2014 - 06/2011
2	Neoplasm Metastasis (Metastasis) 01/2020 - 06/2009
2	Breast Neoplasms (Breast Cancer) 06/2011 - 11/2010
1	Cerebral Hemorrhage 08/2022
1	Ischemic Stroke 08/2022
1	Inflammation (Inflammations) 02/2015
1	Hemorrhagic Shock 02/2015
1	Diarrhea 11/2013
1	Malignant Pleural Effusion 11/2013
1	Exanthema (Rash) 11/2013
1	Esophageal Neoplasms (Esophageal Cancer) 07/2012
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2011
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2011
1	Neutropenia 04/2007
1	Margins of Excision 12/2006
1	Necrosis 03/2006
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 05/2005
1	Hypersensitivity (Allergy) 06/2003
1	Dental Caries (Decay, Dental) 01/2002

Drug/Important Bio-Agent (IBA)

6	Hormones (Hormone)IBA 01/2022 - 10/2007
5	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2002
5	Bevacizumab (Avastin)FDA Link 09/2014 - 06/2011
4	AndrogensIBA 12/2021 - 06/2009
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2014 - 09/2011
2	AntigensIBA 01/2022 - 01/2017
2	Docetaxel (Taxotere)FDA Link 01/2022 - 04/2007
2	ErbB Receptors (EGF Receptor)IBA 09/2014 - 10/2007
2	Biological ProductsIBA 02/2014 - 05/2005
2	Carboplatin (JM8)FDA LinkGeneric 07/2012 - 09/2011
2	Fluorouracil (Carac)FDA LinkGeneric 07/2012 - 09/2011
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2012 - 09/2011
2	DNA (Deoxyribonucleic Acid)IBA 11/2011 - 11/2009
2	Proteins (Proteins, Gene)FDA Link 06/2009 - 10/2002
1	abirateroneIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	LigandsIBA 01/2022
1	Long Noncoding RNAIBA 12/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Dihydrotestosterone (Androstanolone)IBA 01/2018
1	Testosterone (Sustanon)FDA Link 01/2018
1	Serine Proteases (Serine Protease)IBA 01/2017
1	salicylhydroxamic acid (SHAM)IBA 02/2015
1	Carbon MonoxideIBA 02/2015
1	CytokinesIBA 02/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 10/2014
1	Pharmaceutical PreparationsIBA 02/2014
1	Estrogens (Estrogen)FDA Link 06/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2011
1	Fulvestrant (Faslodex)FDA Link 06/2011
1	Anastrozole (Arimidex)FDA LinkGeneric 06/2011
1	Trastuzumab (Herceptin)FDA Link 11/2010
1	Epidermal Growth Factor (EGF)IBA 11/2010
1	vinflunineIBA 11/2010
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2009
1	RNA (Ribonucleic Acid)IBA 11/2009
1	DNA ProbesIBA 11/2009
1	CaspasesIBA 06/2009
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 06/2009
1	Gefitinib (Iressa)FDA Link 10/2007
1	Dermal FillersIBA 03/2006
1	CollagenIBA 06/2003
1	Hyaluronic Acid (Hyaluronan)IBA 06/2003
1	Complementary DNA (cDNA)IBA 10/2002
1	rab GTP-Binding ProteinsIBA 10/2002
1	FluoridesIBA 01/2002

Therapy/Procedure

12	Therapeutics 01/2022 - 06/2009
4	Castration 12/2021 - 02/2014
4	Drug Therapy (Chemotherapy) 09/2014 - 09/2011
3	Radiotherapy 01/2022 - 09/2011
1	Thrombectomy 08/2022
1	Precision Medicine 01/2021
1	Resuscitation 02/2015
1	Neoadjuvant Therapy 07/2012
1	Induction Chemotherapy 09/2011
1	Combined Modality Therapy 09/2011
1	Lasers (Laser) 06/2009
1	Prostatectomy (Retropubic Prostatectomy) 12/2006
1	Fluoridation 01/2002